These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 5498313

  • 21. Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations.
    Zittermann A, Rühl J, Berthold HK, Sudhop T, van der Ven H, Reinsberg J, Stehle P.
    Calcif Tissue Int; 2002 Jan; 70(1):11-21. PubMed ID: 11907703
    [Abstract] [Full Text] [Related]

  • 22. [Markers of bone remodeling: general concepts and clinical significance for skeletal lesions in oncologic patients].
    Liubimova NV, Kushlinskiĭ NE.
    Vopr Onkol; 2001 Jan; 47(1):18-33. PubMed ID: 11317531
    [No Abstract] [Full Text] [Related]

  • 23. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H.
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Morphological findings in the skeletal system in cortisone therapy].
    Könn G.
    Hefte Unfallheilkd; 1969 Aug; 99():136-41. PubMed ID: 5397431
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Autoradiographic and biochemical investigations of the effect of cortisone on the bones of the rat.
    Simmons DJ, Kunin AS.
    Clin Orthop Relat Res; 1967 Aug; 55():201-15. PubMed ID: 6082604
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The influence of adrenal cortical hormones on bone formation and resorption.
    Storey E.
    Clin Orthop Relat Res; 1963 Aug; 30():197-217. PubMed ID: 5889003
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
    Korczowska I, Olewicz-Gawlik A, Hrycaj P, Lacki J.
    Yale J Biol Med; 2003 Aug; 76(2):45-54. PubMed ID: 15369631
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aromatase inhibitor and bone.
    Miki Y, Suzuki T, Sasano H.
    Biomed Pharmacother; 2007 Oct; 61(9):540-2. PubMed ID: 17904790
    [Abstract] [Full Text] [Related]

  • 38. [Action of cortisone on bone growth].
    VIGNOLO W, HOLM N, CAMANO MC, BARSANTINI JC.
    An Fac Med Univ Repub Montev Urug; 1957 Oct; 42(5-6):164-9. PubMed ID: 13533867
    [No Abstract] [Full Text] [Related]

  • 39. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
    Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
    [Abstract] [Full Text] [Related]

  • 40. [Antiresorptive therapy for osteoporosis and bone quality].
    Kishimoto H.
    Clin Calcium; 2005 Jun; 15(6):1007-11. PubMed ID: 15930715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.